Aimovig (erenumab)

pCPA File Number: 21286
Negotiation Status:
Concluded without agreement
Indication(s):
Migraine, Chronic
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
SR0578-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: